Cargando…
Association of Common and Rare Genetic Variation in the 3‐Hydroxy‐3‐Methylglutaryl Coenzyme A Reductase Gene and Cataract Risk
BACKGROUND: Results from animal models and observational studies have raised concerns regarding the potential cataractogenic effects of statin treatment. We investigated whether common and rare genetic variants in HMGCR are associated with cataract risk, to gauge the likely long‐term effects of stat...
Autores principales: | Ghouse, Jonas, Ahlberg, Gustav, Skov, Anne Guldhammer, Bundgaard, Henning, Olesen, Morten S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238641/ https://www.ncbi.nlm.nih.gov/pubmed/35703387 http://dx.doi.org/10.1161/JAHA.122.025361 |
Ejemplares similares
-
The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases
por: Friesen, Jon A, et al.
Publicado: (2004) -
Hypercholesterolemia and 3-Hydroxy 3-Methylglutaryl Coenzyme A Reductase Regulation during Ageing
por: Trapani, Laura, et al.
Publicado: (2009) -
Analysis of Autoantibodies to 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Using Different Technologies
por: Musset, Lucile, et al.
Publicado: (2014) -
Varicose Remodeling of Veins Is Suppressed by 3‐Hydroxy‐3‐Methylglutaryl Coenzyme A Reductase Inhibitors
por: Eschrich, Johannes, et al.
Publicado: (2016) -
Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies
por: Liang, Wen-Chen, et al.
Publicado: (2017)